JP2007508284A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007508284A5 JP2007508284A5 JP2006530602A JP2006530602A JP2007508284A5 JP 2007508284 A5 JP2007508284 A5 JP 2007508284A5 JP 2006530602 A JP2006530602 A JP 2006530602A JP 2006530602 A JP2006530602 A JP 2006530602A JP 2007508284 A5 JP2007508284 A5 JP 2007508284A5
- Authority
- JP
- Japan
- Prior art keywords
- xenon
- administered
- medicament
- use according
- mammal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052724 xenon Inorganic materials 0.000 claims 31
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 claims 31
- 239000003814 drug Substances 0.000 claims 27
- 241000124008 Mammalia Species 0.000 claims 10
- 238000009220 hypothermia therapy Methods 0.000 claims 8
- 206010028923 Neonatal asphyxia Diseases 0.000 claims 6
- 229940079593 drug Drugs 0.000 claims 6
- 206010021113 Hypothermia Diseases 0.000 claims 4
- 206010021143 Hypoxia Diseases 0.000 claims 4
- 208000027418 Wounds and injury Diseases 0.000 claims 4
- 230000036760 body temperature Effects 0.000 claims 4
- 230000006378 damage Effects 0.000 claims 4
- 230000002631 hypothermal effect Effects 0.000 claims 4
- 230000001146 hypoxic effect Effects 0.000 claims 4
- 208000014674 injury Diseases 0.000 claims 4
- 230000000302 ischemic effect Effects 0.000 claims 4
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 claims 2
- 230000003444 anaesthetic effect Effects 0.000 claims 2
- 229960003537 desflurane Drugs 0.000 claims 2
- DPYMFVXJLLWWEU-UHFFFAOYSA-N desflurane Chemical compound FC(F)OC(F)C(F)(F)F DPYMFVXJLLWWEU-UHFFFAOYSA-N 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 229960002725 isoflurane Drugs 0.000 claims 2
- 239000002960 lipid emulsion Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 230000032696 parturition Effects 0.000 claims 2
- 230000010412 perfusion Effects 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 229960002078 sevoflurane Drugs 0.000 claims 2
- DFEYYRMXOJXZRJ-UHFFFAOYSA-N sevoflurane Chemical compound FCOC(C(F)(F)F)C(F)(F)F DFEYYRMXOJXZRJ-UHFFFAOYSA-N 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 230000003376 axonal effect Effects 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000035606 childbirth Effects 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000008774 maternal effect Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000037317 transdermal delivery Effects 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0323861.5 | 2003-10-10 | ||
| GB0323861A GB0323861D0 (en) | 2003-10-10 | 2003-10-10 | Use |
| GB0418539.3 | 2004-08-19 | ||
| GB0418539A GB0418539D0 (en) | 2004-08-19 | 2004-08-19 | Use |
| PCT/GB2004/004298 WO2005034966A1 (en) | 2003-10-10 | 2004-10-11 | Use of xenon with hypothermia for treating neonatal asphyxia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007508284A JP2007508284A (ja) | 2007-04-05 |
| JP2007508284A5 true JP2007508284A5 (enExample) | 2007-11-22 |
| JP4880466B2 JP4880466B2 (ja) | 2012-02-22 |
Family
ID=34436835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006530602A Expired - Fee Related JP4880466B2 (ja) | 2003-10-10 | 2004-10-11 | 新生児仮死を治療するための低体温療法におけるキセノンの使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7390508B2 (enExample) |
| EP (1) | EP1670489B1 (enExample) |
| JP (1) | JP4880466B2 (enExample) |
| AT (1) | ATE380554T1 (enExample) |
| AU (1) | AU2004280118B2 (enExample) |
| BR (1) | BRPI0415232A (enExample) |
| CA (1) | CA2538104C (enExample) |
| DE (1) | DE602004010691T2 (enExample) |
| DK (1) | DK1670489T3 (enExample) |
| ES (1) | ES2298815T3 (enExample) |
| MX (1) | MXPA06003471A (enExample) |
| PT (1) | PT1670489E (enExample) |
| WO (1) | WO2005034966A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2538104C (en) * | 2003-10-10 | 2013-12-10 | Protexeon Limited | Use of xenon with hypothermia for treating neonatal asphyxia |
| GB0418540D0 (en) | 2004-08-19 | 2004-09-22 | Protexeon Ltd | Use |
| GB0520176D0 (en) * | 2005-10-04 | 2005-11-09 | Imp College Innovations Ltd | Use |
| ITMI20071031A1 (it) * | 2007-05-22 | 2008-11-23 | Acetilene & Deriv Ati Siad Spa | Uso di xenon per la protezione di organi da danno ischemico |
| AU2014277860A1 (en) * | 2008-01-22 | 2015-01-22 | Board Of Regents, The University Of Texas System | Volatile anesthetic compositions and methods of use |
| US20110159078A1 (en) * | 2008-01-22 | 2011-06-30 | Vapogenix, Inc | Volatile Anesthetic Compositions and Methods of Use |
| EP3195896A1 (en) * | 2009-05-05 | 2017-07-26 | Board of Regents, The University of Texas System | Novel formulations of volatile anesthetics and methods of use for reducing inflammation |
| CN110464709A (zh) | 2012-08-10 | 2019-11-19 | 德克萨斯州大学系统董事会 | 用于治疗中风的神经保护性脂质体组合物和方法 |
| CN110354067A (zh) | 2013-03-15 | 2019-10-22 | 德克萨斯州大学系统董事会 | 富含稀有气体的液体及其制备和使用方法 |
| FR3021220B1 (fr) * | 2014-05-21 | 2017-08-25 | Air Liquide | Association de xenon et d’un antioxydant pour lutter contre une maladie neurodegenerative de type maladie de parkinson |
| JP6622822B2 (ja) | 2015-06-23 | 2019-12-18 | ノビリス セラピューティクス インコーポレイテッド | 希ガス組成物を用いた治療的な免疫調節 |
| US10022397B2 (en) * | 2016-06-20 | 2018-07-17 | Nobilis Therapeutics, Inc. | Treatment of rheumatoid arthritis using noble gas mixtures |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5099834A (en) * | 1991-07-16 | 1992-03-31 | Union Carbide Industrial Gases Technology Corporation | Method for anesthesia |
| DE19709704C2 (de) * | 1997-03-10 | 1999-11-04 | Michael Georgieff | Verwendung einer flüssigen Präparation von Xenon zur intravenösen Verabreichung bei Einleitung und/oder Aufrechterhaltung der Anaesthesie |
| DE19910986C2 (de) * | 1999-03-11 | 2001-06-07 | Aga Ab | Verwendung von Xenon bei der Behandlung von Neurointoxikationen |
| DE19933704A1 (de) * | 1999-07-19 | 2001-01-25 | Michael Georgieff | Verwendung einer lipophile Gase enthaltenden Präparation zur Neuroprotektion und Neuroregeneration |
| GB9917822D0 (en) * | 1999-07-29 | 1999-09-29 | Imperial College | Nmda antagonist |
| US6653354B2 (en) * | 1999-07-29 | 2003-11-25 | Protexeon Limited | NMDA antagonist comprising xenon |
| WO2001078580A2 (en) * | 2000-03-31 | 2001-10-25 | Innercool Therapies, Inc. | A method combining inducing hypothermia and administering a therapeutic agent |
| CA2538104C (en) * | 2003-10-10 | 2013-12-10 | Protexeon Limited | Use of xenon with hypothermia for treating neonatal asphyxia |
-
2004
- 2004-10-11 CA CA2538104A patent/CA2538104C/en not_active Expired - Fee Related
- 2004-10-11 ES ES04768829T patent/ES2298815T3/es not_active Expired - Lifetime
- 2004-10-11 AT AT04768829T patent/ATE380554T1/de active
- 2004-10-11 MX MXPA06003471A patent/MXPA06003471A/es active IP Right Grant
- 2004-10-11 JP JP2006530602A patent/JP4880466B2/ja not_active Expired - Fee Related
- 2004-10-11 EP EP04768829A patent/EP1670489B1/en not_active Expired - Lifetime
- 2004-10-11 AU AU2004280118A patent/AU2004280118B2/en not_active Ceased
- 2004-10-11 US US10/573,093 patent/US7390508B2/en not_active Expired - Fee Related
- 2004-10-11 DE DE602004010691T patent/DE602004010691T2/de not_active Expired - Lifetime
- 2004-10-11 BR BRPI0415232-8A patent/BRPI0415232A/pt not_active Application Discontinuation
- 2004-10-11 WO PCT/GB2004/004298 patent/WO2005034966A1/en not_active Ceased
- 2004-10-11 DK DK04768829T patent/DK1670489T3/da active
- 2004-10-11 PT PT04768829T patent/PT1670489E/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007508284A5 (enExample) | ||
| Lerman et al. | Manual of pediatric anesthesia | |
| Ayatollahi et al. | Effect of preoperative administration of intravenous paracetamol during cesarean surgery on hemodynamic variables relative to intubation, postoperative pain and neonatal apgar | |
| REAM | Respiratory and cardiac arrest after intravenous administration of kanamycin with reversal of toxic effects by neostigmine | |
| Reynvoet et al. | Epidural dextran 40 patch for postdural puncture headache | |
| Hanusch et al. | Anaesthesia of small rodents during magnetic resonance imaging | |
| Coskun et al. | A comparison of three different target-controlled remifentanil infusion rates during target-controlled propofol infusion for oocyte retrieval | |
| Konefał et al. | Remifentanil patient-controlled analgesia for labor–monitoring of newborn heart rate, blood pressure and oxygen saturation during the first 24 hours after delivery | |
| Vora et al. | Sevoflurane versus propofol in the induction and maintenance of anaesthesia in children with laryngeal mask airway | |
| Weitz et al. | Fatal hepatic necrosis after isoflurane anaesthesia | |
| Yuce et al. | Propofol-ketamine combination has favorable impact on orientation times and pain scores compared to propofol in dilatation and curettage. A randomized trial | |
| CN103977010A (zh) | 一种犬用复方赛拉嗪注射剂及其制备方法 | |
| Wong et al. | Comparison of the Effect of Two Different Doses of 0.75% Glucose‐Free Ropivacaine for Spinal Anesthesia for Lower Limb and Lower Abdominal Surgery | |
| Flaherty | Anaesthetic drugs | |
| Lee et al. | A case of malignant hyperthermia during anesthesia induction with sevoflurane-A case report | |
| Negovetić Vranić et al. | Hitna stanja u dječjoj stomatologiji | |
| Ogurlu et al. | Comparison of bolus remifentanil-propofol versus bolus fentanyl-propofol for dilatation and sharp curettage | |
| Surana et al. | Evaluation of adjunctive analgesia with intrathecal fentanyl along with hyperbaric bupivacaine in spinal anesthesia for elective cesarean section | |
| Klick et al. | Pediatric procedural sedation, analgesia, and anxiolysis | |
| Wilden et al. | Presumed central anticholinergic syndrome from inadvertent intravenous hyoscine hydrobromide (scopolamine) injection | |
| Yousefian et al. | AComparative Study of Ketofol and Thiopental Sodium in Patients undergoing Dilation and Curettage by General Anesthesia | |
| Uğur et al. | Determining the optimal fentanyl dose for dilation and curettage procedures | |
| Abouleish et al. | Caudal anesthesia for vascular access procedures in two extremely small premature neonates | |
| RU2557882C1 (ru) | Способ проведения премедикации при плановом хирургическом лечении | |
| Videnović et al. | Analysis of the applied technique of intravenous anesthesia for in vitro fertilization in obese and patients with normal body mass index |